Telstra warns A$7.3 billion spectrum renewal bill could hit mobile prices
5 March 2026
2 mins read

Telstra warns A$7.3 billion spectrum renewal bill could hit mobile prices

SYDNEY, March 5, 2026, 18:00 AEDT

  • Telstra is calling on Canberra to scale back its proposed mobile spectrum renewal pricing, pressing the issue as the 2026-27 budget approaches.
  • The company argues the regulator’s favored pricing overshoots fair value for the industry by around A$4.1 billion.
  • ACMA is eyeing a projected market value of A$7.34 billion for the renewal of almost 70 licences that are set to expire starting in 2028.

Telstra Group Limited is pressing Australia’s federal government to rein in the price tag on renewing major mobile spectrum licences, cautioning that increased fees could mean either less investment or higher costs for customers.

The Australian Communications and Media Authority (ACMA) is weighing feedback after a public consultation on spectrum — those radio frequencies used for mobile calls and data — wrapped up on Feb. 27. A review of renewal pricing is on the table.

Adam Suckling, deputy chair at ACMA, is backing the renewal of close to 70 licences for Telstra, Optus, TPG Telecom, and NBN Co, pushing the expiry out to 2044. He says the move is about maintaining service continuity and bolstering competition. In his words, ACMA has “determined that … the appropriate projected market value … is $7.34 billion”. ACMA

Telstra said in its most recent submission, filed ahead of the 2026-27 budget, that the industry would end up shelling out roughly A$4.1 billion above fair market value under ACMA’s preferred approach—citing analysis the company had commissioned.

The company is pushing for a sector renewal bill near A$3.3 billion—far less than the estimated A$7.4 billion. For its share, management argues it should face costs closer to A$1.2 billion, instead of the A$2.8 billion figure it described as “on the table”.

Telstra highlighted its A$12.4 billion outlay on mobile networks across seven years to FY25—a figure that includes A$4.7 billion targeted at regional Australia. The company argued that pricier spectrum could eat into future investments for coverage and capacity.

This fight isn’t limited to just a few players—the bands at the heart of the disagreement are crucial for the rivalry between Telstra, Optus and TPG. They also prop up an expanding tier of resellers that rely on network access deals.

Telstra shares slipped 0.58% to A$5.18 late Wednesday, data from Intelligent Investor showed.

Speaking to analysts on Feb. 19, Telstra CEO Vicki Brady said the company has “the capacity, I think, to be able to navigate that period,” but she also flagged that spectrum pricing remains a potential drag on investment decisions. Capital Brief

The dispute isn’t only about the figures. Telstra’s “fair value” argument comes from analysis it paid for. On the other side, ACMA points to international benchmarks, which it says are the right method to value a public asset and ensure taxpayers get a fair return.

If the regulator sticks with its valuation, carriers could end up with little choice but to cut spending, ramp up network sharing deals, or eventually raise prices to manage the extra cost.

Michał Rogucki is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic developments. A graduate of Humboldt University of Berlin, he previously worked in investment research and market analysis before transitioning to financial journalism. He covers the trends and events that matter most to investors worldwide.

Stock Market Today

  • Oceaneering International (OII) Trades Nearly 50% Above Fair Value After Q2 Results
    July 25, 2026, 11:51 AM EDT. Oceaneering International posted Q2 2026 revenue of $768.18M and net income of $65.02M. The company's share price reached $52.73, surging more than 45% this month and 112% year-to-date. However, the stock is viewed as 49.6% overvalued compared to the estimated fair value of $35.25. Key risks cited are a potential decline in offshore oil & gas demand as the global energy transition progresses, which could threaten long-term income.
Eli Lilly stock snaps skid on orforglipron pill data as April FDA clock nears
Previous Story

Eli Lilly stock snaps skid on orforglipron pill data as April FDA clock nears

Lithium price today: Albemarle, SQM drop as China spot market stays choppy
Next Story

Lithium price today: Albemarle, SQM drop as China spot market stays choppy